The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP.
暂无分享,去创建一个
L. Magee | B. Sibai | G. Dekker | M. Brown | G Dekker | A. Tranquilli | B M Sibai | G. Zeeman | A L Tranquilli | L Magee | J Roberts | W Steyn | G G Zeeman | M A Brown | W. Steyn | J. Roberts | M. Brown
[1] François Audibert,et al. Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis , 2010, Obstetrics and gynecology.
[2] G. Gitas,et al. Biomarkers in pre-eclampsia: A novel approach to early detection of the disease , 2012, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[3] A. Seidler,et al. Antiplatelet agents for preventing pre-eclampsia and its complications. , 2007, The Cochrane database of systematic reviews.
[4] M. Brown,et al. Improved methods of assessing proteinuria in hypertensive pregnancy , 1997, British journal of obstetrics and gynaecology.
[5] K. Lim,et al. Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia , 2012, Circulation.
[6] G. D'ottavio,et al. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. , 2012, Placenta.
[7] M. Mugglestone,et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance , 2010, BMJ : British Medical Journal.
[8] James M. Roberts,et al. If we know so much about preeclampsia, why haven't we cured the disease? , 2013, Journal of reproductive immunology.
[9] F. Epstein,et al. Circulating angiogenic factors in gestational proteinuria without hypertension. , 2007, American journal of obstetrics and gynecology.
[10] G. V. van Montfrans,et al. Validation of the Omron M7 and Microlife 3BTO-A Blood Pressure Measuring Devices in Preeclampsia , 2012, Hypertension in pregnancy.
[11] J. Hutcheon,et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model , 2011, The Lancet.
[12] Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy , 2008 .
[13] A. Shennan,et al. Hidden errors of aneroid sphygmomanometers , 2002, Blood pressure monitoring.
[14] Z. Bhutta,et al. PIERS proteinuria: relationship with adverse maternal and perinatal outcome. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[15] M. Brown,et al. Is resistant hypertension really resistant? , 2001, American journal of hypertension.
[16] C. Ris-Stalpers,et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis , 2012, BJOG : an international journal of obstetrics and gynaecology.
[17] L. Magee,et al. The 24-hour urine collection: gold standard or historical practice? , 2008, American journal of obstetrics and gynecology.
[18] B. Payne,et al. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre‐eclampsia using patient data from the PIERS (Pre‐eclampsia Integrated Estimate of RiSk) cohort, collected on admission , 2013, BJOG : an international journal of obstetrics and gynaecology.
[19] C. Homer,et al. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension , 2008, Journal of hypertension.
[20] D. Charnock-Jones,et al. Redefining preeclampsia using placenta-derived biomarkers. , 2013, Hypertension.
[21] R. Riley,et al. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[22] G. Mangos,et al. Can spot urine protein/creatinine ratio replace 24 h urine protein in usual clinical nephrology? , 2006, Nephrology.
[23] H. Odendaal,et al. Do women with pre-eclampsia and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial , 2002 .
[24] R. Ness,et al. Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension , 2005, Hypertension.
[25] R. Liston,et al. The Active Implementation of Pregnancy Hypertension Guidelines in British Columbia , 2010, Obstetrics and gynecology.
[26] D. Henderson-smart,et al. Antiplatelet agents for preventing pre-eclampsia and its complications. , 2007, The Cochrane database of systematic reviews.
[27] M. Brown,et al. Does gestational hypertension become pre‐eclampsia? , 1998, British journal of obstetrics and gynaecology.
[28] Á. Atallah,et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. , 2002, The Cochrane database of systematic reviews.
[29] R. Liston,et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review , 2008, BMJ : British Medical Journal.
[30] R. Haslam,et al. Antioxidants for preventing pre-eclampsia. , 2008, The Cochrane database of systematic reviews.
[31] R. T. Lie,et al. The Interval Between Pregnancies and the Risk of Preeclampsia , 2002 .
[32] B. Sibai,et al. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. , 2003, American journal of epidemiology.
[33] M. Brown. Pre-eclampsia: Proteinuria in pre-eclampsia—does it matter any more? , 2012, Nature Reviews Nephrology.
[34] B. Peretz. The white coat. , 2010, Refu'at ha-peh veha-shinayim.
[35] A. Gülmezoglu,et al. Anticonvulsants for women with pre-eclampsia. , 2000, The Cochrane database of systematic reviews.
[36] M. Brown,et al. A Prospective Study of the Impact of Automated Dipstick Urinalysis on the Diagnosis of Preeclampsia , 2004, Hypertension in pregnancy.
[37] M. Brown,et al. Is there a role for ambulatory blood pressure monitoring in pregnancy? , 2014, Clinical and experimental pharmacology & physiology.
[38] Michael A Black,et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort , 2011, BMJ : British Medical Journal.
[39] S. Roberts,et al. Prediction of pre‐eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high‐performance liquid chromatography , 2011, BJOG : an international journal of obstetrics and gynaecology.
[40] Jan A Staessen,et al. White-coat hypertension: new insights from recent studies. , 2013, Hypertension.
[41] B. Sibai,et al. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). , 2013, Pregnancy hypertension.
[42] G. Davis,et al. Can We Use the Omron T9P Automated Blood Pressure Monitor in Pregnancy? , 2011, Hypertension in pregnancy.
[43] M. Lindheimer,et al. Interpreting Abnormal Proteinuria in Pregnancy: The Need for a More Pathophysiological Approach , 2010, Obstetrics and gynecology.
[44] M. Greene,et al. De Swiet's medical disorders in obstetric practice , 2010 .
[45] G. Saade,et al. First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk , 2012, Obstetrics and gynecology.
[46] Catherine M. Brown,et al. Hypertension in pregnancy: is it time for a new approach to treatment? , 2012, Journal of hypertension.
[47] D. A. Green,et al. New Insights From Recent Studies in Historical Astronomy: Following in the Footsteps of F. Richard Stephenson , 2015 .
[48] R. Rodrigo,et al. Prediction of early and late pre‐eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[49] Jean-Marie Moutquin,et al. The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.
[50] G. Dekker,et al. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. , 2009, Journal of reproductive immunology.
[51] B. Sibai,et al. Cardiology patient page. Chronic hypertension in pregnancy. , 2007, Circulation.
[52] J. Langhoff‐Roos,et al. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort , 2012, Journal of thrombosis and haemostasis : JTH.
[53] G. Dekker,et al. Guidelines for the management of hypertensive disorders of pregnancy 2008 , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.
[54] A. Polyakov,et al. The accuracy of spot urinary protein‐to‐creatinine ratio in confirming proteinuria in pre‐eclampsia , 2012, The Australian & New Zealand journal of obstetrics & gynaecology.
[55] C. Homer,et al. The natural history of white coat hypertension during pregnancy , 2005, BJOG : an international journal of obstetrics and gynaecology.